Arrayit (ARYC) Stock Price, News & Analysis

Company Overview

Arrayit Corporation was a biotechnology company that developed microarray-based technologies for life-sciences research and clinical diagnostics. Its platform was designed to analyze large numbers of biological markers simultaneously, supporting applications in genomics, proteomics, drug discovery and disease testing.

The company offered DNA, protein and peptide microarrays, along with related laboratory instruments, reagents and testing services. Arrayit also developed allergy-testing products, including its AllerArray platform, and provided contract research and diagnostic services to pharmaceutical, academic and clinical customers.

Founded in California, Arrayit served customers in the United States and international markets. Mark Schena, a co-inventor of the DNA microarray, was identified in company materials as the company’s founder and chief executive. Arrayit was formerly quoted on the OTC Markets under the symbol ARYC; publicly available information about its current operations and leadership is limited.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 9/24/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:ARYC
• CIK: 1084507
• Web: www.arrayit.com
• Phone: (408) 744-1331
• Fax: 408-744-1711
• Employees: 7
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A